A comprehensive diagnostic offering workflow increases the rate of actionable results of the 23- and 35-gene expression profile tests for use as ancillary diagnostic tools for difficult-to-diagnose melanocytic lesions. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 6, p. s79, 2021. DOI: 10.25251/skin.5.supp.79. Disponível em: https://skin.dermsquared.com/skin/article/view/1430. Acesso em: 18 may. 2025.